PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 20 filers reported holding PLX PHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $1,000 | -88.9% | 394 | -69.7% | 0.00% | – |
Q2 2019 | $9,000 | +50.0% | 1,300 | +8.3% | 0.00% | – |
Q1 2019 | $6,000 | -82.4% | 1,200 | -85.7% | 0.00% | – |
Q3 2018 | $34,000 | – | 8,412 | +420500.0% | 0.00% | – |
Q2 2018 | $0 | – | 2 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 2 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $403,000 | 0.96% |
Park West Asset Management LLC | 1,075,723 | $6,918,000 | 0.41% |
683 Capital Management, LLC | 249,300 | $1,603,000 | 0.17% |
Heritage Way Advisors, LLC | 28,000 | $180,000 | 0.15% |
Harel Insurance Investments & Financial Services Ltd. | 250,000 | $145,000 | 0.01% |
UBS Group AG | 11,840 | $76,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 2 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,302 | $8,000 | 0.00% |
FAYEZ SAROFIM & CO | 13,729 | $89,000 | 0.00% |
DEUTSCHE BANK AG\ | 2 | $0 | 0.00% |